CND Life Sciences Announces Publication of Study Demonstrating Clinical Utility of the Syn-One Test® as an Important Aid in the Diagnosis and Treatment of Neurodegenerative Diseases
Findings from retrospective chart review of patients with suspected Parkinson’s disease and related disorders show the use of skin biopsy for detection of abnormal synuclein in cutaneous nerves yielded changes in clinical diagnosis or treatment in over 75% of cases SCOTTSDALE, Ariz., Dec. 18,
Donatos Pizza Fuels Growth and Innovation in 2024
Kevin King Named CEO as Premium Pizza Franchise Drives Future Expansion and Franchise Development COLUMBUS, Ohio, Dec. 18, 2024 /PRNewswire/ — Donatos Pizza, the pizza franchise famous for its abundance of toppings, is closing 2024 on a high note, with transformational leadership changes and
Lab Automation Market to Hit USD 7.71 Billion by 2029 with 6.9% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Dec. 18, 2024 /PRNewswire/ — The global lab automation market is expected to reach USD 7.71 Billion by 2029 from USD 5.85 Billion in 2024, growing at a CAGR of 6.9 % during the forecast period. The major driving forces of the lab automation market comprise rising needs for
Commercial Real Estate Market to Grow by USD 384.46 Billion (2024-2028); Global Commercial Sector Growth Boosting Market, AI Driving Transformation – Technavio
NEW YORK, Dec. 18, 2024 /PRNewswire/ — Report with the AI impact on market trends – The global commercial real estate market size is estimated to grow by USD 384.46 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 4.36% during the forecast per
NeuroSense Provides Business Update and Third Quarter 2024 Financial Results
CAMBRIDGE, Mass., Dec. 18, 2024 /PRNewswire/ — NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), a late-stage clinical biotechnology company developing novel treatments for severe neurodegenerative diseases, today provided business update with corporate highlights to dat
Exero Medical Announces Enrollment of 100th Patient in Pivotal Study to Validate its Breakthrough Technology for Early Detection of Post Operative Complications
OR YEHUDA, Israel, Dec. 18, 2024 /PRNewswire/ — The study, which includes eleven sites in the US and Israel, is enrolling patients undergoing colorectal resection surgery to validate the safety and accuracy of Exero’s xBar system for early detection of major, life-threatening complicati
Karmanos Cancer Institute Physicians Begin Prescribing New FDA-approved Radiofrequency Electromagnetic Device to Treat Advanced Liver Cancer
Karmanos is the first in the world with access to this innovative treatment that uses radiofrequencies to target and shrink cancerous tumors DETROIT, Dec. 18, 2024 /PRNewswire/ — The Barbara Ann Karmanos Cancer Institute, the largest provider of cancer care and research in Michigan and part o
TeachTown Named 2024 Excellence in Equity – Industry Impact Award Winner in Two Categories
WOBURN, Mass., Dec. 18, 2024 /PRNewswire/ — The American Consortium for Equity in Education announced that TeachTown was named a winner of the 2024 Excellence in Equity – Industry Impact Award in two categories: Company of the Year – PreK-12 and Early Childhood Solution. The Industry I
Real Estate’s Rocking in the New Year Returns: Ready to Thrive in 2025
NORWALK, Conn., Dec. 18, 2024 /PRNewswire/ — As the real estate industry gears up for another dynamic year, RISMedia is excited to announce the return of its signature virtual event, Real Estate’s Rocking in the New Year – Ready to Thrive in 2025, on Thursday, January 9, 2025, fro
G-SHOCK Revitalizes Iconic Classics with the New Origin Revival DW5000R
Celebrating G-SHOCK’s timeless legacy, the reimagined timepiece combines original designs with advanced technology DOVER, N.J., Dec. 18, 2024 /PRNewswire/ — Today, Casio America, Inc. is proud to announce the release of the DW5000R-1A Origin Revival model – a tribute to G-SHOCK&
